Identification of Subpopulations Exhibiting the Greatest Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide-1 Receptor Agonists—A Combined Analysis of Large Cardiovascular Outcome Trials

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1064-P
Author(s):  
YU MI KANG ◽  
YUN KYUNG CHO ◽  
JONG HAN CHOI ◽  
CHANGYUN WOO ◽  
WOO JE LEE ◽  
...  
Keyword(s):  
Cardiovascular Outcome ◽  
Combined Analysis ◽  
Cardiovascular Outcome Trials ◽  
Receptor Agonists ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Long Acting ◽  
Cardiovascular Benefit

scholarly journals Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials With Meta-Analysis

Stroke ◽  
2020 ◽  
Vol 51 (2) ◽  
pp. 666-669 ◽  
Author(s):  
Giuseppe Bellastella ◽  
Maria Ida Maiorino ◽  
Miriam Longo ◽  
Lorenzo Scappaticcio ◽  
Paolo Chiodini ◽  
...  
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Cardiovascular Outcome ◽  
Cardiovascular Outcome Trials ◽  
Receptor Agonists ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1
Sign in / Sign up

Export Citation Format

Share Document